Diabetes
55:1537-1545,
2006
DOI: 10.2337/db06-0263
© 2006 by the American Diabetes Association
Adipose TissueFrom Lipid Storage Compartment to Endocrine Organ
Philipp E. Scherer
Cell Biology and Medicine, Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx, New York
Address correspondence and reprint requests to Departments of Cell Biology and Medicine, Diabetes Research and Training Center, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. E-mail: scherer{at}aecom.yu.edu
Abbreviations:
AMPK, AMP-activated protein kinase; ER, endoplasmic reticulum; HMW, high molecular weight; IL, interleukin; PPAR, peroxisome proliferatior–activated receptor; RELM, resistin-like molecule; ROS, reactive oxygen species; TZD, thiazolidinedione
Adipose tissue, when carried around in excessive amounts, predisposes to a large number of diseases. Epidemiological data show that the prevalence of obesity has significantly increased over the past 20 years and continues to do so at an alarming rate. Here, some molecular aspects of the key constituent of adipose tissue, the adipocyte, are reviewed. While the adipocyte has been studied for many years and remarkable insights have been gained about some processes, many areas of the physiology of the fat cell remain unexplored. Our understanding of how cellular events in the adipocyte affect the local environment through paracrine interactions and how systemic effects are achieved through endocrine interactions is rudimentary. While storage and release of lipids are major functions of adipocytes, the adipocyte also uses specific lipid molecules for intracellular signaling and uses a host of protein factors to communicate with essentially every organ system in the body. The intensity and complexity of these signals are highly regulated, differ in each fat pad, and are dramatically affected by various disease states.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Tedesco, A. Valerio, C. Cervino, A. Cardile, C. Pagano, R. Vettor, R. Pasquali, M. O. Carruba, G. Marsicano, B. Lutz, et al.
Cannabinoid Type 1 Receptor Blockade Promotes Mitochondrial Biogenesis Through Endothelial Nitric Oxide Synthase Expression in White Adipocytes
Diabetes,
August 1, 2008;
57(8):
2028 - 2036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Koh, J.-Y. Park, H.-S. Park, M. J. Jeon, J. W. Ryu, M. Kim, S. Y. Kim, M.-S. Kim, S.-W. Kim, I. S. Park, et al.
Essential Role of Mitochondrial Function in Adiponectin Synthesis in Adipocytes
Diabetes,
December 1, 2007;
56(12):
2973 - 2981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pachler, D. Ikeoka, J. Plank, H. Weinhandl, M. Suppan, J. K. Mader, M. Bodenlenz, W. Regittnig, H. Mangge, T. R. Pieber, et al.
Subcutaneous adipose tissue exerts proinflammatory cytokines after minimal trauma in humans
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E690 - E696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Khazen, E. Distel, M. Collinet, V. E. Chaves, J.-P. M'Bika, C. Chany, A. Achour, C. Benelli, and C. Forest
Acute and Selective Inhibition of Adipocyte Glyceroneogenesis and Cytosolic Phosphoenolpyruvate Carboxykinase by Interferon {gamma}
Endocrinology,
August 1, 2007;
148(8):
4007 - 4014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Febbraio
Exercise and inflammation
J Appl Physiol,
July 1, 2007;
103(1):
376 - 377.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Semple, N. H. Halberg, K. Burling, M. A. Soos, T. Schraw, J. Luan, E. K. Cochran, D. B. Dunger, N. J. Wareham, P. E. Scherer, et al.
Paradoxical Elevation of High-Molecular Weight Adiponectin in Acquired Extreme Insulin Resistance Due to Insulin Receptor Antibodies
Diabetes,
June 1, 2007;
56(6):
1712 - 1717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Modan-Moses, D. Stein, C. Pariente, A. Yaroslavsky, A. Ram, M. Faigin, R. Loewenthal, E. Yissachar, R. Hemi, and H. Kanety
Modulation of Adiponectin and Leptin during Refeeding of Female Anorexia Nervosa Patients
J. Clin. Endocrinol. Metab.,
May 1, 2007;
92(5):
1843 - 1847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Fantuzzi and T. Mazzone
Adipose Tissue and Atherosclerosis: Exploring the Connection
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2007;
27(5):
996 - 1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Alvarez-Llamas, E. Szalowska, M. P. de Vries, D. Weening, K. Landman, A. Hoek, B. H. R. Wolffenbuttel, H. Roelofsen, and R. J. Vonk
Characterization of the Human Visceral Adipose Tissue Secretome
Mol. Cell. Proteomics,
April 1, 2007;
6(4):
589 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Grundy
Metabolic Syndrome: A Multiplex Cardiovascular Risk Factor
J. Clin. Endocrinol. Metab.,
February 1, 2007;
92(2):
399 - 404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Shore
Obesity and asthma: lessons from animal models
J Appl Physiol,
February 1, 2007;
102(2):
516 - 528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Trujillo and P. E. Scherer
Adipose Tissue-Derived Factors: Impact on Health and Disease
Endocr. Rev.,
December 1, 2006;
27(7):
762 - 778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Corvera, A. Burkart, J.-Y. Kim, J. Christianson, Z. Wang, and P. E. Scherer
Keystone meeting summary: 'Adipogenesis, obesity, and inflammation' and 'Diabetes mellitus and the control of cellular energy metabolism, ' January 21-26, 2006, Vancouver, Canada.
Genes & Dev.,
August 15, 2006;
20(16):
2193 - 2201.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|